The low molecular weight S-nitrosothiol, S-nitroso-N-acetylpenicillamine, promotes cell cycle progression in rabbit aortic endothelial cells

Nitric Oxide - Biology and Chemistry

Volumn 18, Issue 4, 2008, Pages 241-255

  Oliveira, Carlos Jorge R ^a   Curcio, Marli F ^a   Moraes, Miriam S ^a   Tsujita, Maristela ^a   Travassos, Luiz R ^a   Stern, Arnold ^b   Monteiro, Hugo P ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cell cycle; Cyclins; Endothelial cells; Nitric oxide; Nitrosothiols; S Nitrosylation

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 6; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; N ACETYL S NITROSOPENICILLAMINE; P21 ACTIVATED KINASE; RETINOBLASTOMA PROTEIN; S NITROSOTHIOL; TRANSCRIPTION FACTOR E2F; TRANSCRIPTION FACTOR ELK 1;

ANIMAL CELL; ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL NUCLEUS; ENDOTHELIUM CELL; NITROSATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; AORTA; CELL CYCLE; CELLS, CULTURED; CYCLIN-DEPENDENT KINASES; CYCLINS; ENDOTHELIAL CELLS; ENZYME ACTIVATION; ETS-DOMAIN PROTEIN ELK-1; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MOLECULAR WEIGHT; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS P21(RAS); RABBITS; RETINOBLASTOMA PROTEIN; S-NITROSO-N-ACETYLPENICILLAMINE; S-NITROSOTHIOLS;

ORYCTOLAGUS CUNICULUS;

EID: 42749083113     PISSN: 10898603     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.niox.2008.02.001     Document Type: Article

References (50)

1. Sherr C.J. Cancer cell cycles. Science 274 (1996) 1672-1677
2. Sherr C.J., and Roberts J.M. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 13 (1999) 1501-1512
3. Morgan D.O. Cyclin-dependent kinases: engines, clocks, and microprocessors. Annu. Rev. Cell Dev. 13 (1997) 261-291
4. Kato J. Induction of S phase by regulatory factors. Front. Biosci. 4 (1999) 787-795
5. Weinberg R.A. The retinoblastoma protein and cell cycle control. Cell 81 (1995) 323-330
6. Hall M., and Peters G. Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer. Adv. Cancer Res. 68 (1996) 67-108
7. Lundberg A.S., and Weinberg R.A. Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes. Mol. Cell. Biol. 18 (1998) 753-761
8. Wu C.L., Zukerberg L.R., Ngwu C., Harlow E., and Lees J.A. In vivo association of E2F and DP family proteins. Mol. Cell. Biol. 15 (1995) 2536-2546
9. Geng Y., Whoriskey O.W., Park M.Y., Bronson R.T., Medena R.H., Li T., Weinberg R.A., and Sicinski P. Rescue of cyclin D1 deficiency by knockin-down cyclin E. Cell 97 (1999) 767-777
10. Desdouets C., Sobczak-Thepot J., Murphy M., and Brechot C. Cyclin A: function and expression during cell proliferation. Prog. Cell Cycle Res. 1 (1995) 115-123
11. Mulcahy L.S., Smith M.R., and Stacey D.W. Requirement for ras proto-oncogene function during serum-stimulated growth of NIH 3T3 cells. Nature 313 (1985) 241-243
12. Feig L.A., and Cooper G.M. Inhibition of NIH3T3 cell proliferation by a mutant ras protein with preferential affinity for GDP. Mol. Cell. Biol. 8 (1988) 3235-3243
13. Vojtek A.B., and Der C.J. Increasing complexity of the Ras signaling pathway. J. Biol. Chem. 273 (1998) 19925-19928
14. Kolch W. Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions. Biochem. J. 351 (2000) 289-305
15. Gille H., and Downward J. Multiple Ras effector pathways contribute to G1 cell cycle progression. J. Biol. Chem. 274 (1999) 22033-22040
16. MAPK pathway. J. Biol. Chem. 271 (1996) 20608-20616
17. Cheng M., Sexl V., Sherr C.J., and Roussel M.F. Assembly of cyclin D-dependent kinase and titration of p27Kip1 regulated by mitogen-activated protein kinase (MEK1). Proc. Natl. Acad. Sci. USA 95 (1998) 1091-1096
18. Weber J.D., Hu W., Jefcoat Jr. S.C., Raben D.M., and Baldassare J.J. Ras-stimulated extracellular signal-related kinase 1 and RhoA activities coordinate platelet-derived growth factor-induced G1 progression through the independent regulation of cyclin D1 and p27. J. Biol. Chem. 272 (1997) 32966-32971
19. Pillay I., and Sharma S.V. In vivo and in vitro serine/threonine phosphorylations of epidermal growth factor receptor upon entry into cell cycle. Cell Growth Differ. 6 (1995) 39-49
20. Dimmeler S., and Zeiher A.M. Nitric oxide and apoptosis: another paradigm for the double-edged role of nitric oxide. Nitric Oxide 1 (1997) 275-281
21. Gruetter D.Y., Gruetter C.A., Barry B.K., Baricos W.H., Hyman A.L., Kadowitz P.J., and Ignarro L.J. Activation of coronary arterial guanylate cyclase by nitric oxide, nitroprusside, and nitrosoguanidine--inhibition by calcium, lanthanum, and other cations, enhancement by thiols. Biochem. Pharmacol. 29 (1980) 2943-2950
22. Hess D.T., Matsumoto A., Kim S.-O., Marshall H.E., and Stamler J. Protein S-nitrosylation: purview and parameters. Nat. Rev. Mol. Cell Biol. 6 (2005) 150-166
23. Oliveira C.J.R., Schindler F., Ventura A.M., Moraes M.S., Arai R.J., Debbas V., Stern A., and Monteiro H.P. Nitric oxide and cGMP activate the Ras-MAP kinase pathway stimulating protein tyrosine phosphorylation in rabbit aortic endothelial cells. Free Radic Biol. Med. 35 (2003) 381-396
24. Buonassisi V., and Venter J.C. Hormone and neurotransmitter receptors in an established vascular endothelial cell line. Proc. Natl. Acad. Sci. USA 73 (1976) 1612-1616
25. Vinals F., and Pouysségur J. Confluence of vascular endothelial cells induces cell cycle exit by inhibiting p42/p44 mitogen-activated protein kinase activity. Mol. Cell. Biol. 19 (1999) 2763-2772
26. Reffas S., and Schlegel W. Compartment-specific regulation of extracellular signal-regulated kinase (ERK) and c-Jun N-terminal kinase (JNK) mitogen-activated protein kinases (MAPKs) by ERK-dependent and non-ERK-dependent inductions of MAPK phosphatase (MKP)-3 and MKP-1 in differentiating P19 cells. Biochem. J. 352 (2000) 701-708
27. Herrmann C., Martin G., and Wittinghofer A. Quantitative analysis of the complex between p21ras and the Ras-binding domain of the human Raf-1 protein kinase. J. Biol. Chem. 270 (1995) 2901-2905
28. de Rooij J., and Bos J.L. Minimal Ras-binding domain of Raf1 can be used as an activation-specific probe for Ras. Oncogene 14 (1997) 623-625
29. Lenormand P., Brondello J.M., Brunet A., and Pouysségur J. Growth factor-induced p42/p44 MAPK nuclear translocation and retention requires both MAPK activation and neosynthesis of nuclear anchoring proteins. J. Cell Biol. 142 (1998) 625-633
30. Murphy L.O., and Blenis J. MAPK signal specificity: the right place at the right time. Trends Biochem. Sci. 31 (2006) 268-275
31. Lander H.M., Hajjar D.P., Hempstead B.L., Mirza U.A., Chait B.T., Campbell S., and Quilliam L.A. A molecular redox switch on p21(ras). Structural basis for the nitric oxide-p21(ras) interaction. J. Biol. Chem. 272 (1997) 4323-4326
32. Chuang C.-F., and Ng S.-Y. Functional divergence of the MAP kinase pathway ERK1 and ERK2 activate specific transcription factors. FEBS Lett. 346 (1994) 229-234
33. Quelle D.E., Ashmun R.A., Shurtleff S.A., Kato J.Y., Bar S.D., Roussel M.F., and Sherr C.J. Over-expression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts. Genes Dev. 7 (1993) 1559-1571
34. Baldin V., Lukas J., Marcote M.J., Pagano M., and Draetta G. Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev. 7 (1993) 812-821
35. Jiang W., Kahn S.M., Zhou P., Zhang Y.J., Cacace A., Infante A.S., Doi S., Santella R.M., and Weinstein I.B. Over-expression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression. Oncogene 8 (1993) 3447-3457
36. Resnitzky D., Gossen M., Bujard H., and Reed S.I. Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system. Mol. Cell. Biol. 14 (1994) 1669-1679
37. Lukas J., Bartkova J., Welcker M., Petersen O.W., Peters G., Strauss M., and Bartek J. Cyclin D2 is a moderately oscillating nucleoprotein required for G1 phase progression in specific cell types. Oncogene 10 (1995) 2125-2134
38. Kim P.K.M., Zamora R., Petrosko P., and Billiar T.R. The regulatory role of nitric oxide in apoptosis. Int. Immunopharmacol. 1 (2001) 1421-1441
39. Jarry A., Charrier L., Bou-Hanna C., Devilder M.-C., Crussaire V., Dennis M.G., Vallette G., and Laboisse C.L. Position in cell cycle controls the sensitivity of colon cancer cells to nitric oxide-dependent programmed cell death. Cancer Res. 64 (2004) 4227-4234
40. Takagi K., Sobe Y., Yasukawa K., Okouchi E., and Suketa Y. Nitric oxide blocks the cell cycle of mouse macrophage-like cells in the early G2 + M phase. FEBS Lett. 340 (1994) 159-162
41. Tanner F.C., Meier P., Greutert H., Champion C., Nabel E.G., and Lüscher T.F. Nitric oxide modulates expression of cell cycle regulatory proteins. Circulation 101 (2000) 1982-1989
42. Shao C., Furusawa Y., and Aoki M. Sper/NO-induced reversible proliferation inhibition and cell cycle arrests associated with a micronucleus induction in HSG cells. Nitric Oxide 8 (2003) 83-88
43. Traister A., Abashidze S., Gold V., Plachta N., Karchovsky E., Patel K., and Weil M. Evidence that nitric oxide regulates cell-cycle progression in the developing chick neuroepithelium. Dev. Dyn. 225 (2002) 271-276
44. Barbosa de Oliveira L.C., Rocha Oliveira C.J., Fries D.M., Stern A., and Monteiro H.P. Effects of lipopolysaccharide on low- and high-density cultured rabbit vascular smooth muscle cells: differential modulation of nitric oxide release, ERK1/ERK2 MAP kinase activity, protein tyrosine phosphatase activity, and DNA synthesis. Braz. J. Med. Biol. Res. 35 (2002) 181-190
45. Jablonska-Shariff A., and Olson L.M. The role of nitric oxide in oocyte meiotic maturation and ovulation: meiotic abnormalities of endothelial nitric oxide synthase knock-out mouse oocytes. Endocrinology 139 (1998) 2944-2954
46. Huo L.J., Liang C.G., Yu L.Z., Yang Z.M., Fan H.Y., Chen D.Y., and Sun Q.Y. Inducible nitric oxide synthase-derived nitric oxide regulates germinal vesicle breakdown and first polar body emission in the mouse oocyte. Reproduction 129 (2005) 403-409
47. Tao Y., Xie H., Hong H., Chen X., Jang J., and Xia G. Effects of nitric oxide synthase inhibitors on porcine oocyte meiotic maturation. Zygote 13 (2005) 1-9
48. Bergers G., and Benjamin L.E. Tumorigenesis and the angiogenic switch. Nat. Rev. Cancer 3 (2003) 401-410
49. Gallo O., Masini E., Morbidelli L., Franchi A., Fini-Storchi I., Vergari W.A., and Ziche M. Role of nitric oxide in angiogenesis and tumor progression in head and neck cancer. J. Natl. Cancer Inst. 90 (1998) 587-596
50. Fukumura D., Kashiwagi S., and Jain R.K. The role of nitric oxide in tumor progression. Nat. Rev. Cancer 6 (2006) 521-534